In focus
Latest feed
The Unseen Weight: Oncologists and the Profound Burden of Grief
A Breakthrough on the Horizon: Daraxonrasib Offers New Hope for Pancreatic Cancer Patients
D3 Bio Unveils Breakthrough First‑Line Results for ELISRASIB at ASCO 2026
D3 Bio’s First‑Line Data Shows Landmark Efficacy of Elisrasib in KRAS G12C‑Positive NSCLC
